Andere Kunden interessierten sich auch für
![The role of TNF ¿¿, IL-8 and peripheral blood lymphocyts in HCV patient]( "The role of TNF ¿¿, IL-8 and peripheral blood lymphocyts in HCV patient")
The role of TNF ¿¿, IL-8 and peripheral blood lymphocyts in HCV patient23,99 €![Can TTV and SENV affect the out come of HCV?]( "Can TTV and SENV affect the out come of HCV?")
Can TTV and SENV affect the out come of HCV?36,99 €![Sero-prevalence of HBV and HCV in chronic liver disease patients]( "Sero-prevalence of HBV and HCV in chronic liver disease patients")
Sero-prevalence of HBV and HCV in chronic liver disease patients32,99 €![The Medical Importance of Probiotics and HCV Infection]( "The Medical Importance of Probiotics and HCV Infection")
The Medical Importance of Probiotics and HCV Infection36,99 €![Determination of HCV Genotypes in Khyber Pakhtunkhawa]( "Determination of HCV Genotypes in Khyber Pakhtunkhawa")
Determination of HCV Genotypes in Khyber Pakhtunkhawa32,99 €![Hepatitis Delta Virus]( "Hepatitis Delta Virus")
Hepatitis Delta Virus74,99 €![A importância médica dos probióticos e da infeção por HCV]( "A importância médica dos probióticos e da infeção por HCV")
A importância médica dos probióticos e da infeção por HCV29,99 €
HCV, a major cause of liver disease worldwide, is frequently resistant to the antiviral interferon- therapy, being the only approved treatment available. It has been investigated recently that interleukin-8 (IL-8) induced by HCV partially inhibit the IFN- therapy. Therefore we aimed to prospectively utilize the baseline IL-8 levels in the HCV infected serum and predict its role in sustained virological response (SVR) to IFN- + ribavirin therapy, in chronic HCV patients. Fifteen normal volunteers and 110 HCV patients were enrolled in this study. Their baseline IL-8 levels were determined by ELISA and pre & post-treatment viral loads were recorded using qPCR. Different response rates to the therapy were observed and significant correlation was found between baseline IL-8 level and response to IFN therapy (P0.01). Comparatively higher mean baseline IL-8 levels were observed in non-responders (2442.02 ±159.92 pg/ml), than the late (1009.31 ±45.31) and rapid (540.91 ±27.06 pg/ml) responders. Baseline IL-8 measurement should be used as a management tool before deciding the therapy, being involved in pathogenesis, persistence and resistance to antiviral therapy.